Form 4 for BIIB Biogen
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001127602-23-020235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-05 | 2023-06-30 | BIIB | Singhal Priya | Head of Development | F - Tax | $284.85 | -153 | 3,005 | -5% | -$43.6K |
| D | 2023-07-05 | 2023-07-03 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $282.87 | -81 | 2,924 | -3% | -$22.9K |
| D | 2023-07-05 | 2023-06-30 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +315 | 3,158 | +11% | $0 |
| D | 2023-07-05 | 2023-06-30 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -315 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | F | D | 153 | $284.85 | 3,005.09 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-03 | S | D | 81 | $282.87 | 2,924.09 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-30 | M | A | 315 | $0.00 | 3,158.09 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2023-06-30 | M | D | 315 | $0.00 | 0 | D | $0.00 · — to 2023-07-01 | 315 Common Stock | (F1) This award was granted to the reporting person on July 1, 2020 and vested in three equal installments on each anniversary of the grant date. |